Is hyperprogressive disease a specific phenomenom of immunotherapy?

Hyperprogressive disease (HPD) is a novel pattern of response during immunotherapy treatment. Several retrospective studies have evaluated its prevalence among various cancer types and, in particular, in non-small cell lung cancer patients, based on different definition criteria. If HPD is a just a...

Full description

Bibliographic Details

Published in:	Exploration of Targeted Anti-tumor Therapy
Main Authors:	Marta Brambilla, Giuseppe Lo Russo, Roberto Ferrara, Sara Manglaviti, Marina Chiara Garassino, Mario Occhipinti
Format:	Article
Language:	English
Published:	Open Exploration Publishing Inc. 2020-12-01
Subjects:	hyperprogressive disease immunotherapy chemotherapy-immunotherapy
Online Access:	https://www.explorationpub.com/Journals/etat/Article/100227